1. Home
  2. BAX vs MEDP Comparison

BAX vs MEDP Comparison

Compare BAX & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BAX
  • MEDP
  • Stock Information
  • Founded
  • BAX 1931
  • MEDP 1992
  • Country
  • BAX United States
  • MEDP United States
  • Employees
  • BAX N/A
  • MEDP N/A
  • Industry
  • BAX Medical/Dental Instruments
  • MEDP Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • BAX Health Care
  • MEDP Health Care
  • Exchange
  • BAX Nasdaq
  • MEDP Nasdaq
  • Market Cap
  • BAX 11.3B
  • MEDP 13.4B
  • IPO Year
  • BAX N/A
  • MEDP 2016
  • Fundamental
  • Price
  • BAX $17.90
  • MEDP $585.82
  • Analyst Decision
  • BAX Hold
  • MEDP Hold
  • Analyst Count
  • BAX 10
  • MEDP 11
  • Target Price
  • BAX $27.00
  • MEDP $451.70
  • AVG Volume (30 Days)
  • BAX 7.9M
  • MEDP 347.3K
  • Earning Date
  • BAX 10-30-2025
  • MEDP 10-22-2025
  • Dividend Yield
  • BAX 3.78%
  • MEDP N/A
  • EPS Growth
  • BAX N/A
  • MEDP 25.36
  • EPS
  • BAX N/A
  • MEDP 14.32
  • Revenue
  • BAX $11,023,000,000.00
  • MEDP $2,358,373,000.00
  • Revenue This Year
  • BAX $5.72
  • MEDP $21.48
  • Revenue Next Year
  • BAX $2.52
  • MEDP $11.90
  • P/E Ratio
  • BAX N/A
  • MEDP $41.35
  • Revenue Growth
  • BAX 3.90
  • MEDP 13.88
  • 52 Week Low
  • BAX $17.47
  • MEDP $250.05
  • 52 Week High
  • BAX $37.74
  • MEDP $625.00
  • Technical
  • Relative Strength Index (RSI)
  • BAX 20.23
  • MEDP 62.02
  • Support Level
  • BAX $17.47
  • MEDP $572.12
  • Resistance Level
  • BAX $18.16
  • MEDP $602.54
  • Average True Range (ATR)
  • BAX 0.56
  • MEDP 20.93
  • MACD
  • BAX -0.45
  • MEDP -0.69
  • Stochastic Oscillator
  • BAX 7.81
  • MEDP 59.40

About BAX Baxter International Inc.

Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: